Intercept Pharmaceuticals Inc
NASDAQ:ICPT
Income Statement
Earnings Waterfall
Intercept Pharmaceuticals Inc
Revenue
|
317.7m
USD
|
Cost of Revenue
|
-632k
USD
|
Gross Profit
|
317.1m
USD
|
Operating Expenses
|
-372.1m
USD
|
Operating Income
|
-55.1m
USD
|
Other Expenses
|
-6.5m
USD
|
Net Income
|
-61.6m
USD
|
Income Statement
Intercept Pharmaceuticals Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
2
N/A
|
2
-2%
|
2
+3%
|
2
+2%
|
2
+2%
|
2
-1%
|
3
+65%
|
3
N/A
|
3
N/A
|
3
N/A
|
2
-36%
|
7
+282%
|
12
+69%
|
25
+116%
|
46
+82%
|
71
+56%
|
107
+51%
|
131
+22%
|
146
+11%
|
159
+9%
|
164
+4%
|
180
+9%
|
196
+9%
|
219
+12%
|
234
+7%
|
252
+8%
|
272
+8%
|
283
+4%
|
301
+6%
|
313
+4%
|
322
+3%
|
313
-3%
|
300
-4%
|
261
-13%
|
263
+1%
|
266
+1%
|
277
+4%
|
286
+3%
|
295
+3%
|
306
+4%
|
318
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(6)
|
(7)
|
(5)
|
(5)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
21
N/A
|
52
+146%
|
93
+80%
|
130
+40%
|
144
+11%
|
157
+8%
|
162
+3%
|
177
+10%
|
193
+9%
|
216
+12%
|
231
+7%
|
248
+7%
|
268
+8%
|
278
+4%
|
294
+6%
|
307
+5%
|
316
+3%
|
309
-2%
|
298
-4%
|
260
-13%
|
261
+1%
|
265
+1%
|
276
+4%
|
285
+3%
|
294
+3%
|
306
+4%
|
317
+4%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(34)
|
(41)
|
(54)
|
(69)
|
(94)
|
(115)
|
(136)
|
(162)
|
(178)
|
(232)
|
(319)
|
(353)
|
(389)
|
(428)
|
(405)
|
(432)
|
(451)
|
(465)
|
(471)
|
(473)
|
(470)
|
(463)
|
(487)
|
(504)
|
(536)
|
(560)
|
(580)
|
(578)
|
(562)
|
(526)
|
(481)
|
(435)
|
(400)
|
(360)
|
(350)
|
(353)
|
(355)
|
(353)
|
(458)
|
(464)
|
(372)
|
|
Selling, General & Administrative |
(11)
|
(13)
|
(16)
|
(21)
|
(27)
|
(35)
|
(42)
|
(55)
|
(71)
|
(104)
|
(181)
|
(202)
|
(222)
|
(274)
|
(244)
|
(269)
|
(286)
|
(274)
|
(275)
|
(273)
|
(269)
|
(256)
|
(270)
|
(275)
|
(295)
|
(317)
|
(339)
|
(362)
|
(358)
|
(335)
|
(295)
|
(246)
|
(215)
|
(177)
|
(170)
|
(166)
|
(168)
|
(176)
|
(196)
|
(210)
|
(212)
|
|
Research & Development |
(23)
|
(28)
|
(37)
|
(47)
|
(66)
|
(80)
|
(94)
|
(107)
|
(107)
|
(128)
|
(138)
|
(151)
|
(167)
|
(154)
|
(160)
|
(163)
|
(165)
|
(192)
|
(196)
|
(200)
|
(202)
|
(207)
|
(217)
|
(229)
|
(241)
|
(243)
|
(241)
|
(216)
|
(204)
|
(192)
|
(186)
|
(189)
|
(185)
|
(183)
|
(180)
|
(187)
|
(187)
|
(177)
|
(170)
|
(163)
|
(160)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(92)
|
(92)
|
0
|
|
Operating Income |
(32)
N/A
|
(40)
-23%
|
(52)
-32%
|
(67)
-28%
|
(92)
-37%
|
(113)
-23%
|
(133)
-18%
|
(160)
-20%
|
(175)
-10%
|
(229)
-31%
|
(317)
-38%
|
(346)
-9%
|
(377)
-9%
|
(403)
-7%
|
(359)
+11%
|
(362)
-1%
|
(345)
+5%
|
(336)
+3%
|
(327)
+3%
|
(316)
+3%
|
(309)
+2%
|
(286)
+7%
|
(294)
-3%
|
(288)
+2%
|
(305)
-6%
|
(312)
-2%
|
(312)
+0%
|
(300)
+4%
|
(268)
+11%
|
(219)
+18%
|
(164)
+25%
|
(126)
+23%
|
(102)
+19%
|
(101)
+2%
|
(89)
+12%
|
(88)
+0%
|
(79)
+11%
|
(68)
+14%
|
(165)
-142%
|
(159)
+4%
|
(55)
+65%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(54)
|
(28)
|
(251)
|
(190)
|
(169)
|
(171)
|
56
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(14)
|
(21)
|
(29)
|
(29)
|
(29)
|
(30)
|
(30)
|
(30)
|
(31)
|
(31)
|
(33)
|
(37)
|
(41)
|
(45)
|
(47)
|
(47)
|
(48)
|
(49)
|
(49)
|
(51)
|
(54)
|
(49)
|
(43)
|
(34)
|
(21)
|
(18)
|
(14)
|
(10)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
(13)
|
(13)
|
(13)
|
16
|
17
|
17
|
17
|
(92)
|
(92)
|
0
|
0
|
(6)
|
|
Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
4
|
5
|
4
|
5
|
5
|
6
|
6
|
7
|
7
|
7
|
8
|
9
|
10
|
8
|
6
|
4
|
4
|
4
|
3
|
2
|
0
|
(1)
|
2
|
7
|
9
|
14
|
14
|
|
Pre-Tax Income |
(86)
N/A
|
(68)
+21%
|
(304)
-348%
|
(257)
+15%
|
(261)
-2%
|
(283)
-9%
|
(77)
+73%
|
(158)
-106%
|
(173)
-10%
|
(226)
-31%
|
(314)
-39%
|
(343)
-9%
|
(381)
-11%
|
(413)
-8%
|
(376)
+9%
|
(385)
-2%
|
(369)
+4%
|
(360)
+2%
|
(352)
+2%
|
(341)
+3%
|
(333)
+2%
|
(309)
+7%
|
(318)
-3%
|
(314)
+1%
|
(335)
-6%
|
(345)
-3%
|
(347)
-1%
|
(339)
+2%
|
(321)
+5%
|
(275)
+14%
|
(222)
+19%
|
(184)
+17%
|
(135)
+27%
|
(136)
-1%
|
(120)
+12%
|
(115)
+4%
|
(202)
-76%
|
(175)
+14%
|
(173)
+1%
|
(159)
+8%
|
(57)
+64%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(86)
|
(68)
|
(304)
|
(257)
|
(261)
|
(283)
|
(77)
|
(158)
|
(173)
|
(226)
|
(314)
|
(343)
|
(381)
|
(413)
|
(376)
|
(385)
|
(369)
|
(360)
|
(352)
|
(341)
|
(333)
|
(309)
|
(318)
|
(314)
|
(335)
|
(345)
|
(347)
|
(339)
|
(321)
|
(275)
|
(222)
|
(184)
|
(135)
|
(136)
|
(120)
|
(115)
|
(202)
|
(175)
|
(173)
|
(159)
|
(57)
|
|
Net Income (Common) |
(86)
N/A
|
(68)
+21%
|
(304)
-348%
|
(257)
+15%
|
(261)
-2%
|
(283)
-9%
|
(77)
+73%
|
(158)
-106%
|
(173)
-10%
|
(226)
-31%
|
(314)
-39%
|
(343)
-9%
|
(381)
-11%
|
(413)
-8%
|
(376)
+9%
|
(385)
-2%
|
(369)
+4%
|
(360)
+2%
|
(352)
+2%
|
(341)
+3%
|
(333)
+2%
|
(309)
+7%
|
(318)
-3%
|
(314)
+1%
|
(335)
-6%
|
(345)
-3%
|
(347)
-1%
|
(339)
+2%
|
(321)
+5%
|
(275)
+14%
|
(222)
+19%
|
(170)
+23%
|
(107)
+37%
|
(91)
+15%
|
(68)
+25%
|
(65)
+5%
|
206
N/A
|
222
+7%
|
207
-7%
|
209
+1%
|
(62)
N/A
|
|
EPS (Diluted) |
-4.49
N/A
|
-3.76
+16%
|
-14.73
-292%
|
-11.56
+22%
|
-12.26
-6%
|
-13.63
-11%
|
-3.45
+75%
|
-6.57
-90%
|
-7.14
-9%
|
-9.56
-34%
|
-12.8
-34%
|
-13.94
-9%
|
-15.4
-10%
|
-16.71
-9%
|
-15.08
+10%
|
-15.39
-2%
|
-14.7
+4%
|
-14.35
+2%
|
-13.9
+3%
|
-11.66
+16%
|
-11.22
+4%
|
-10.86
+3%
|
-10.68
+2%
|
-10.03
+6%
|
-10.22
-2%
|
-10.89
-7%
|
-10.66
+2%
|
-10.29
+3%
|
-9.72
+6%
|
-8.34
+14%
|
-6.7
+20%
|
-5.12
+24%
|
-3.38
+34%
|
-2.86
+15%
|
-2.29
+20%
|
-2.17
+5%
|
6.01
N/A
|
6.55
+9%
|
4.96
-24%
|
4.99
+1%
|
-1.47
N/A
|